Results 91 to 100 of about 4,003 (221)
Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis [PDF]
, 2009 In a phase III study of lansoprazole treatment, patients with healed or unhealed erosive esophagitis entered a titrated open-label treatment period and received lansoprazole for ≤6 years to assess long-term maintenance therapy.
Thomas O. Kovacs +5 more
core +1 more source
Zollinger–Ellison syndrome: modern aspects of diagnostics and treatment
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2014 The aim of review. To reflect modern concepts on clinic, diagnostics and treatment of Zollinger–Ellison syndrome (ZES).Key points. ZES is rare disease related to intragastric hyperacidity.
I. V. Mayev +3 more
doaj
A simple scoring model for advanced colorectal neoplasm in asymptomatic subjects aged 40–49 years [PDF]
, 2017 BACKGROUND: Limited data are available for advanced colorectal neoplasm in asymptomatic individuals aged 40–49 years. We aimed to identify risk factors and develop a simple prediction model for advanced colorectal neoplasm in these persons.
Hee Sun Kim +6 more
core +1 more source
Meta-analyses: Does long-term PPI use increase the risk of gastric premalignant lesions? [PDF]
, 2013 Background: Proton pump inhibitors (PPIs) are the most effective agents available for reducing acid secretion. They are used for medical treatment of various acid-related disorders.
Eslami, L., Nasseri-Moghaddam, S.
core
Hypertrophic pyloric stenosis in infants: is it a congenital or acquired disorder? Reflections on 2 cases [PDF]
, 2014 Based on evidence from two collected and treated clinical observations of hypertrophic pyloric stenosis in children of 5 and 12 months of age, the authors give their point of view on the unresolved issue of the etiology of hypertrophic pyloric stenosis ...
Faustin Mouafo Tambo +4 more
core +1 more source
BMC Veterinary Research, 2017 Background Serum gastrin concentration can help diagnose gastrinomas in dogs if >3–10× the upper reference limit (URL), but antisecretory therapy and other conditions can also cause hypergastrinemia.
Romy M. Heilmann +5 more
doaj +1 more source
European Journal of Inflammation, 2013 Type IIIb polyglandular autoimmune disease comprises autoimmune thyroid disease (HT) and chronic atrophic gastritis (AIG). Hypergastrinemia, secondary to AIG, predisposes to gastric enterochromaffin-like cell (ECL) hyperplasia, a preneoplastic condition.
A. Renzullo +12 more
doaj +1 more source
The 100 most influential manuscripts in gastric cancer: a bibliometric analysis [PDF]
, 2016 Background Bibliometric analysis highlights the key topics and publications which have shaped the understanding and management of Gastric cancer. Here the 100 most cited manuscripts in the field of gastric cancer (GC) are analysed.
Hughes, Daniel +3 more
core +2 more sources
Hypergastrinemia and enterochromaffin-like cell hyperplasia.
The Yale journal of biology and medicine, 1998 The enterochromaffin-like (ECL) cells, the most frequent endocrine cells of the oxyntic mucosa of the stomach, are under the trophic stimulus of gastrin. These cells undergo a hyperplastic increase in variety of hypergastrinemic diseases. The most widely accepted nomenclature for the description of hyperplastic proliferation has been retrospectively ...
DELLE FAVE, Gianfranco +5 more
openaire +2 more sources
Journal of Pharmacological Sciences, 2003 Menetrier’s disease is characterized by giant gastric folds with foveolar hyperplasia and cystic dilatation, hypoproteinemia, and enhanced mucus secretion. The etiology remains unresolved and an effective treatment has yet to be established. Here we show
Toshiki Ogawa +5 more
doaj +1 more source